Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 356080, 5 pages
http://dx.doi.org/10.1155/2014/356080
Research Article

Association between the Delta Estimated Glomerular Filtration Rate and the Prevalence of Monoclonal Gammopathy of Undetermined Significance in Korean Males

Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Republic of Korea

Received 24 February 2014; Revised 12 April 2014; Accepted 22 April 2014; Published 8 May 2014

Academic Editor: Patrizia Cardelli

Copyright © 2014 Tae-Dong Jeong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Dispenzieri, J. A. Katzmann, R. A. Kyle et al., “Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study,” The Lancet, vol. 375, no. 9727, pp. 1721–1728, 2010. View at Publisher · View at Google Scholar
  2. R. A. Kyle, T. M. Therneau, S. V. Rajkumar et al., “Prevalence of monoclonal gammopathy of undetermined significance,” The New England Journal of Medicine, vol. 354, no. 13, pp. 1362–1369, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. H.-K. Park, K.-R. Lee, Y.-J. Kim et al., “Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population,” American Journal of Hematology, vol. 86, no. 9, pp. 752–755, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. K. Wadhera and S. V. Rajkumar, “Prevalence of monoclonal gammopathy of undetermined significance: a systematic review,” Mayo Clinic Proceedings, vol. 85, no. 10, pp. 933–942, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Stratta, L. Gravellone, T. Cena et al., “Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience,” Critical Reviews in Oncology/Hematology, vol. 79, no. 1, pp. 31–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Katzmann, R. J. Clark, R. S. Abraham et al., “Serum reference intervals and diagnostic ranges for free κ and free λ immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains,” Clinical Chemistry, vol. 48, no. 9, pp. 1437–1444, 2002. View at Google Scholar · View at Scopus
  7. N. Korde, S. Y. Kristinsson, and O. Landgren, “Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies,” Blood, vol. 117, no. 21, pp. 5573–5581, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Iwanaga, M. Tagawa, K. Tsukasaki, S. Kamihira, and M. Tomonaga, “Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan,” Mayo Clinic Proceedings, vol. 82, no. 12, pp. 1474–1479, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. P. Wu, A. Minter, R. Costello et al., “MGUS prevalence in an ethnically Chinese population in Hong Kong,” Blood, vol. 121, no. 12, pp. 2363–2364, 2013. View at Publisher · View at Google Scholar
  10. G. Cohen and W. H. Hörl, “Free immunoglobulin light chains as a risk factor in renal and extrarenal complications,” Seminars in Dialysis, vol. 22, no. 4, pp. 369–372, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Bargnoux, N. Simon, V. Garrigue et al., “Glomerular filtration rate as a determinant of free light chains in renal transplantation,” Clinical Biochemistry, vol. 46, no. 16-17, pp. 1764–1766, 2013. View at Publisher · View at Google Scholar
  12. J. Bladé, “Monoclonal gammopathy of undetermined significance,” The New England Journal of Medicine, vol. 355, no. 26, pp. 2765–2770, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. P. Bida, R. A. Kyle, T. M. Therneau et al., “Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients,” Mayo Clinic Proceedings, vol. 84, no. 8, pp. 685–693, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. R. A. Kyle and S. Kumar, “The significance of monoclonal gammopathy of undetermined significance,” Haematologica, vol. 94, no. 12, pp. 1641–1644, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. O. Landgren, G. Gridley, I. Turesson et al., “Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States,” Blood, vol. 107, no. 3, pp. 904–906, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. S. Levinson, “Hook effect with lambda free light chain in serum free light chain assay,” Clinica Chimica Acta, vol. 411, no. 21-22, pp. 1834–1836, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Li, H. Geng, Z. Yang, and R. Zhong, “Influence of immunoglobulin light chain dimers on the results of the quantitative nephelometric assay,” Clinical Laboratory, vol. 57, no. 1-2, pp. 53–57, 2011. View at Google Scholar · View at Scopus
  18. S. S. Levinson, “Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio,” Annals of Clinical and Laboratory Science, vol. 40, no. 4, pp. 348–353, 2010. View at Google Scholar · View at Scopus
  19. A. R. Bradwell, H. D. Carr-Smith, G. P. Mead et al., “Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine,” Clinical Chemistry, vol. 47, no. 4, pp. 673–680, 2001. View at Google Scholar · View at Scopus